Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Partnering bevacizumab with irinotecan as first line-therapy of metastatic colorectal cancer improves progression free survival-A retrospective analysis.
Cainap C, Ungur RA, Bochis OV, Achimas P, Vlad C, Havasi A, Vidrean A, Farcas A, Tat T, Gherman A, Piciu A, Bota M, Constantin AM, Pop LA, Maniu D, Crisan O, Cioban CV, Balacescu O, Coza O, Balacescu L, Marta MM, Dronca E, Cainap S. Cainap C, et al. Among authors: tat t. PLoS One. 2021 Apr 28;16(4):e0248922. doi: 10.1371/journal.pone.0248922. eCollection 2021. PLoS One. 2021. PMID: 33909622 Free PMC article.
Treatment beyond progression in metastatic colorectal cancer: to double or not to double the dose of bevacizumab?
Bochiș OV, Vlad C, Căinap C, Achimaș Cadariu P, Sur D, Havasi A, Vidrean A, Mureșan A, Piciu A, Bota M, Constantin AM, Tat T, Maniu D, Crișan O, Vasile Cioban C, Bălăcescu O, Coza O, Bălăcescu L, Marta MM, Căinap S. Bochiș OV, et al. Among authors: tat t. J BUON. 2020 Mar-Apr;25(2):875-883. J BUON. 2020. PMID: 32521881 Free article.
Doubling the Dose of Bevacizumab Beyond Progression in Metastatic Colorectal Cancer-the Experience of a Tertiary Cancer Center.
Căinap C, Bochiş OV, Vlad C, Popita R, Achimaş-Cadariu P, Havasi A, Vidrean A, Dranca A, Piciu A, Constantin AM, Tat T, Dana M, Crişan O, Cioban CV, Bălăcescu O, Coza O, Bălăcescu L, Marta MM, Bota M, Căinap S. Căinap C, et al. Among authors: tat t. Front Pharmacol. 2021 Mar 11;12:487316. doi: 10.3389/fphar.2021.487316. eCollection 2021. Front Pharmacol. 2021. PMID: 33776758 Free PMC article.
Neutrophil extracellular trapping and angiogenesis biomarkers after intravenous or inhalation anaesthesia with or without intravenous lidocaine for breast cancer surgery: a prospective, randomised trial.
Galoș EV, Tat TF, Popa R, Efrimescu CI, Finnerty D, Buggy DJ, Ionescu DC, Mihu CM. Galoș EV, et al. Br J Anaesth. 2020 Nov;125(5):712-721. doi: 10.1016/j.bja.2020.05.003. Epub 2020 Jun 29. Br J Anaesth. 2020. PMID: 32616309 Free article. Clinical Trial.
Permanent fluidic magnets for liquid bioelectronics.
Zhao X, Zhou Y, Song Y, Xu J, Li J, Tat T, Chen G, Li S, Chen J. Zhao X, et al. Among authors: tat t. Nat Mater. 2024 May;23(5):703-710. doi: 10.1038/s41563-024-01802-6. Epub 2024 Apr 26. Nat Mater. 2024. PMID: 38671161
66 results